Molecular Testing for Advanced Colorectal Cancer

Molecular Testing for Advanced Colorectal Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Prognostic and Predictive Markers in Colorectal Cancer

February 26th 2016

EP. 2: Practical Considerations in Molecular Testing in CRC

February 26th 2016

EP. 3: Colorectal Cancer: Challenges in Next-Generation Sequencing

February 26th 2016

EP. 4: The Current Status of RAS Testing in Colorectal Cancer

February 26th 2016

EP. 5: EGFR Therapy as Upfront Colorectal Cancer Treatment

February 26th 2016

EP. 6: Upfront EGFR Therapy in Metastatic Colorectal Cancer

February 26th 2016

EP. 7: Pathways of Resistance in Metastatic Colorectal Cancer

February 26th 2016

EP. 8: BRAF Testing in Colorectal Cancer

February 26th 2016

EP. 9: Microsatellite Instability Status in Colorectal Cancer

February 26th 2016

EP. 10: PI3K-Mutant Metastatic Colorectal Cancer

February 26th 2016

EP. 11: Potential Biomarkers in Metastatic Colorectal Cancer

February 26th 2016

Trending on OncLive

FDA Approves Aminolevulinic Acid Hydrochloride Plus PDT for Basal Cell Carcinoma

FDA Approves Reduced Monitoring Time for First 2 Doses of Tarlatamab in ES-SCLC

Dr Gandara on Expanding Beyond PD-L1 as a Biomarker in NSCLC

Dr Gandara on the KRAS G12C Survival Signal With Cemiplimab in EMPOWER-Lung 1

PAPILLON: Frontline Amivantamab Plus Chemotherapy Yields 34.3-Month Median OS in EGFR Exon 20 Insertion–Positive NSCLC